logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5529.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5529.produseast1
World Malaria Day 2022 | Collections | MSF Science Portal
World Malaria Day 2022

World Malaria Day 2022

Collection Content

Journal Article
|
Research

Prevalence of malaria in an area receiving seasonal malaria chemoprevention in Niger

Coldiron ME, Assao B, Guindo O, Sayinzoga-Makombe N, Koskalova A,  et al.
2021-10-24 • Malaria Journal
2021-10-24 • Malaria Journal
BACKGROUND
Malaria transmission is highly seasonal in Niger. Despite the introduction of seasonal malaria chemoprevention (SMC) in the Magaria District, malaria incidence remains hig...
Conference Material
|
Abstract

Revision of the epidemiological situation of malaria in Burundi and the potential implications for future control

Leclair C, Marien J, Sinzinkayo D, Abdelrahman A, Lampaert E,  et al.
2021-05-19 • MSF Scientific Days International 2021: Research
2021-05-19 • MSF Scientific Days International 2021: Research
INTRODUCTION
In Burundi, malaria continues to be a major public health issue as the leading cause of health facility attendance, high levels of mortality and devastating malaria epid...
Conference Material
|
Slide Presentation

Feasibility of large-scale mass drug administration? for malaria in Angumu health zone, DRC

Sterk E, Newport T, Mahamat TA, Gitahi P, Mandagot JJ,  et al.
2021-05-19 • MSF Scientific Days International 2021: Research
2021-05-19 • MSF Scientific Days International 2021: Research
Journal Article
|
Research

Identification of main malaria vectors and their insecticide resistance profile in internally displaced and indigenous communities in Eastern Democratic Republic of the Congo (DRC)

Loonen JACM, Dery DB, Musaka BZ, Bandibabone JB, Bousema T,  et al.
2020-11-23 • Malaria Journal
2020-11-23 • Malaria Journal
BACKGROUND
Malaria remains a major public health concern in the Democratic Republic of the Congo (DRC) and its control is affected by recurrent conflicts. Médecins Sans Frontières (M...
Journal Article
|
Commentary

Needs and challenges in modelling malaria for emergency contexts

Boëte C, Guardiola M, Lasry E, Burza S, Moriana S,  et al.
2020-09-01 • Trends in Parasitology
2020-09-01 • Trends in Parasitology
While modelling is an essential component for an understanding of the epidemiology of malaria, and for designing better control measures, it rarely considers the particular contexts enco...
Conference Material
|
Slide Presentation

Use of population pharmacokinetics to assess adherence to amodiaquine used for seasonal malaria chemoprevention

Coldiron ME
2020-05-13 • MSF Scientific Days International 2020
2020-05-13 • MSF Scientific Days International 2020

See more collections

Snake envenoming: a neglected crisis
Snake envenoming: a neglected crisis

Every year 2 million or more people fall victim to snakebite envenoming, mostly in poor, rural communities of Africa, Asia and Latin America. Between 83,000—138,000 of them die, while hundreds of thousands more suffer debilitating long-term complications or disabilities.


Although some antivenom medicines are highly effective when used promptly and appropriately, many snakebite victims get no treatment at all. Those who do may receive antivenoms which don’t work against the type of snake that bit them, or were not rigorously tested for safety and effectiveness.


To mark World Snakebite Awareness Day on September 19th, the Collection linked below brings together recent MSF work on this highly neglected disease. Several articles and conference presentations help fill evidence gaps on the burden of disease and its impacts or on treatment outcomes with specific antivenoms in specific regions. Others examine how to tackle the formidable challenges of availability and affordability, the absence of regulatory oversight for making, testing and registering antivenoms, and the anemic R&D pipeline for new products—all of which impede access for patients to safe, effective treatment tailored to local snake species.

Snakebite envenoming: a neglected health crisis
Snakebite envenoming: a neglected health crisis

Every year 2 million or more people fall victim to snakebite envenoming, mostly in poor, rural communities of Africa, Asia and Latin America. Between 83,000—138,000 of them die, while hundreds of thousands more suffer debilitating long-term complications or disabilities.


Although some antivenom medicines are highly effective when used promptly and appropriately, many snakebite victims get no treatment at all. Those who do may receive antivenoms which don’t work against the type of snake that bit them, or were not rigorously tested for safety and effectiveness.


To mark World Snakebite Awareness Day on September 19th, the Collection linked below brings together recent MSF work on this highly neglected disease. Several articles and conference presentations help fill evidence gaps on the burden of disease and its impacts or on treatment outcomes with specific antivenoms. Others examine how to tackle the formidable challenges of availability and affordability, the absence of regulatory oversight for making, testing and registering antivenoms, and the anemic R&D pipeline for new products—all of which impede access for patients to safe, effective treatment tailored to local snake species.

MSF logo
International Women's Day 2023
No description available
View All Collections